Novelos Shakes Class Action Over Cancer Drug Statements
A Massachusetts federal judge on Thursday tossed a securities class action against Novelos Therapeutics Inc., ruling that the pharmaceutical company's CEO did not mislead investors about the prospects of a developmental-stage...To view the full article, register now.
Already a subscriber? Click here to view full article